Polyester & ePTFE based graft receives European CE Mark
19 Mar '11
3 min read
MAQUET's Portfolio of Vascular Grafts All MAQUET vascular grafts are designed for optimal patient outcomes and feature technologies to improve hemostasis, encourage tissue in-growth, promote natural healing and provide long-term durability.
The FUSION BIOLINE graft is the latest addition to MAQUET Cardiovascular's portfolio of market-leading surgical grafts, which includes the HEMASHIELD line of aortic grafts, the most used and most studied vascular grafts in the world cardiothoracic surgical market.
More than 2 million HEMASHIELD grafts have been implanted in patients worldwide, with clearly demonstrated clinical efficacy and improved outcomes. MAQUET's INTERGARD grafts include the innovative INTERGARD Knitted grafts with reverse Locknit construction to resist postoperative dilatation, the INTERGARD ULTRATHIN heparin-coated graft, designed to promote graft patency, and INTERGARD SILVER, the world's first antimicrobial surgical graft.